New & Improved!

Submit a New & Noteworthy
November 2018
Manufacturing Expansion
By: QuVa Pharma, Inc

Manufacturing Expansion

QuVa Pharma has commenced manufacturing in newly completed Suites 4 and 5 at its facility in Bloomsbury, New Jersey, substantially increasing capacity. As the company experiences significant growth, these two new compounding suites will allow an increase in total output of compounded sterile preparations by more than 50%. Customer demand for compounded sterile medications sourced from FDA approved product has become a dominant driver of the company’s future business; as such, added capacity will allow QuVa to satisfy increasing customer demand for sterile sourced product well into 2019.

QuVa Pharma, Inc

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register:

    As of May 24, 2018, www.pppmag.com's Terms of Use and Privacy Policy have been updated.
    You can review the Terms of Use HERE and the Privacy Policy HERE.
    By continuing to use www.pppmag.com, you are agreeing to these changes.